2018 Seminar Series
Dec 14th, 2018: Dr. Manpreet Singh: “Measuring Obesity and Mood Effects on Neurobehaviors ThroUgh Maturation (MOMENTUM): A Research Update”
Dec 7th, 2018: Dr. Roel Nusse: “Organ-Specific Stem Cells; the Liver”
Dr. Robert Whitener (Kim Lab): “Bringing a new model to Stanford: Using the pig to study islet cell development”
Nov 30th, 2018: CSB cutting edge lecture series: Dr. Paolo Sassone Corsi: “Epigenetics and Metabolism: The Circadian Clock Link”
Nov 23rd, 2018: No seminar due to Thanksgiving break
Nov 16th, 2018: CSB cutting edge lecture series: Dr Philip Scherer: “Systemic Contributions of the Adipocyte in Diabetes, Obesity and Cancer”. Munzer Auditorium 12:30-1:30pm
Nov 9th, 2018: Dr. Latha Palaniappan: “Physical Activity Interventions in Type 2 Diabetes”
Nov 2nd, 2018: Andrew Posselt (Professor of Surgery and Director of Pancreatic Islet Program at UCSF): “Clinical islet transplantation, the UCSF experience”
Greg Szot (Core Manager, Islet Production Core at UCSF): “Pancreatic islet cell processing and cell therapy”
Oct 26th, 2018: Graham Barlow (Bollyky/Nolan labs): “Progression of Pancreatic and Immune Tissue Architecture During Type I Diabetes”
Oct 19th, 2018: Vivek Bhalla: “Role of Esm-1 as a Kidney-enriched Inhibitor of Leukocyte Infiltration and Albuminuria in Diabetic Nephropathy”
Baohui Xu (Dalman Lab): “Aortic aneurysm inhibition in diabetes”
Oct 12th, 2018: No seminar due to ISPAD 2018 conference overlap
Oct 5th, 2018: Katja Pekrun (Kay lab): “DirectedEvolution of AAV for Islet Targeting”
Andrew Lipchik(Snyder lab): “Antibody-mediated inhibition of mitochondrial respiration as a predictor of insulin resistance”
Sept 28th, 2018: Jon Piganelli (Associate Professor, Children’s Hospital of Pittsburgh): “Adaptive but Not Terminal UPR Induces Human β cell Immunogenicity: First Step in the Progression of β cell Destruction”
Sept 21st, 2018: Jiehan Li (Ingelsson lab): “Genetic screening in adipocytes: combining CRISPR perturbations and single-cell RNA sequencing”
Francois Haddad: “Precision Initiatives in Diabetic Cardiomyopathy”
Sept 14th, 2018: Peter Robinson: “A new method for detecting antibody biomarkers in autoimmune diabetes”
Molly Tanenbaum: “Human factors as a pathway to improving diabetes care”
Sept 7th, 2018: Gozde Durmus (Thakor lab): “Levitating Pancreatic Tissues for Islet Transplantation”
Kimberly Tsui (Bassik lab): “Uncovering genetic modulators of Antibody-Drug Conjugate toxicity using CRISPR/Cas9 Screens”
Jun 15th, 2018: Christopher Gardner: “Recruitment Strategies for Trials – Lessons Learned, Resource Being Created”
May 18th, 2018: Dr. Mohsen Fathzadeh (Knowles): “The human lipodystrophy-like gene FAM13A affects fat distribution and function in mice”
Dr. Katrin Svensson: “Isthmin-1 is a hormone that regulates peripheral glucose homeostasis”
May 11th, 2018: Eric Appel: “Innovations in Insulin Formulation by Supramolecular Design”
Apr 6th, 2018: Kyle Loh: “Prospects for using human embryonic stem cells to treat diabetes: replacing the immune system or generating pancreatic progenitors?"
Hannah Moeller (Annes Lab): “Discovering Pathways Promoting Beta-Cell Identity and Function”
Mar 30th, 2018: Dr. Eyal Dassau: “The Artificial Pancreas and Connected Diabetes Care: A Patient Centric Design”
Mar 23rd, 2018: Dr. Garrison Fathman: “A novel approach to rejuvenate endogenous Treg function in the treatment of autoimmune diseases; can one drug treat all these diseases?” (Discussion session led by the leaders)
Mar 16th, 2018: Dr. Rick Kraemer: “Cholesterol trafficking for steroidogenesis”
Dr. Maurizio Morri (Ingelsson lab): “CRISPR-based high-throughput screening and validation of putative candidate genes for insulin resistance”
Mar 9th, 2018: No seminar
Mar 2nd, 2018: No seminar
Feb 23rd, 2018: Dr. Jeffrey Liu (Roncarolo lab): “Engineering Tr1 cells to induce immune tolerance”
Dr. Nadine Nagy: “4-methylumbelliferyl Glucuronide Inhibits Hyaluronan Synthesis and Promotes Foxp3+ Regulatory T-cell Induction”
Feb 16th, 2018: Zahra Bahrami-Nejad (Teruel lab): “A core component of mature adipocytes enforces cell identity by mediating adipocyte differentiation”
Dr. Terry Unterman: “Regulatory Networks in Diabetes: Integrated Regulation of Hepatic Glucose and Lipid Metabolism by FoxO Proteins”
Feb 9th, 2018: Jason Tsai (Bertozzi lab): “Sensitive and multiplex quantification of anti-Islet cell antibodies for Type 1 Diabetes diagnostics and risk assessments”
Dr. Anisha Patel: “Examining Policies to Promote Access to Free Water in Schools as an Alternative to Sugar Sweetened Beverages”
Feb 2nd, 2018: Monte Winslow: “Genome Engineering in the Mouse Pancreas/Marina Basina: Managing Type 2 Diabetes: Where are we in 2018?”
Jan 26th, 2018: Dr. Everett Meyer: “Defining disease associated invariant NKT in human type 1 diabetes”
Dr. Paul Bollyky: “IL-2 delivery and immune modulation in type 1 diabetes”
Jan 12th, 2018: Tom Soh: “Technology for continuously measuring specific biomolecules in vivo”
Korey Hood: “Science of Behavior: Opportunities to Optimize Diabetes Outcomes”
Jan 10, 2018: Invited guest speaker - Danny Chou, PhD, Assistant Professor, University of Utah: "Toward Optimal Insulin Action and Performance for People with Diabetes"